- Home
- LDI vs CADL Comparison
LDI vs CADL Comparison
Compare LDI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- CADL
- Stock Information
- Founded
- LDI 2010
- CADL 1999
- Country
- LDI United States
- CADL United States
- Employees
- LDI N/A
- CADL N/A
- Industry
- LDI Finance: Consumer Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- CADL Health Care
- Exchange
- LDI Nasdaq
- CADL Nasdaq
- Market Cap
- LDI 221.2M
- CADL 234.8M
- IPO Year
- LDI 2021
- CADL 2021
- Fundamental
- Price
- LDI $1.31
- CADL $5.45
- Analyst Decision
- LDI Sell
- CADL Strong Buy
- Analyst Count
- LDI 3
- CADL 4
- Target Price
- LDI $1.98
- CADL $21.00
- AVG Volume (30 Days)
- LDI 735.5K
- CADL 991.5K
- Earning Date
- LDI 05-06-2025
- CADL 05-13-2025
- Dividend Yield
- LDI N/A
- CADL N/A
- EPS Growth
- LDI N/A
- CADL N/A
- EPS
- LDI N/A
- CADL N/A
- Revenue
- LDI $1,090,719,000.00
- CADL N/A
- Revenue This Year
- LDI $28.75
- CADL N/A
- Revenue Next Year
- LDI $15.05
- CADL N/A
- P/E Ratio
- LDI N/A
- CADL N/A
- Revenue Growth
- LDI 21.07
- CADL N/A
- 52 Week Low
- LDI $1.01
- CADL $3.79
- 52 Week High
- LDI $3.23
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- LDI 60.49
- CADL 50.27
- Support Level
- LDI $1.18
- CADL $5.18
- Resistance Level
- LDI $1.36
- CADL $6.29
- Average True Range (ATR)
- LDI 0.08
- CADL 0.41
- MACD
- LDI 0.02
- CADL 0.08
- Stochastic Oscillator
- LDI 81.48
- CADL 42.89
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.